Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin T Jordan

Showing results (51-60 of 92) with videos related to

Pageof 10
Sort By:
The Laryngoscope|June 13, 2025
Increased Hemorrhage During Excision of Bevacizumab-Treated NF2-Related Vestibular SchwannomasChristopher G Wood, Liana Kozanno, Anat Stemmer-Rachamimov, et al.
Contemporary Clinical Trials|August 29, 2022
Design of a randomized, placebo-controlled, phase 2 study evaluating the safety and efficacy of tanezumab for treatment of schwannomatosis-related painJennifer L W Da, Vanessa L Merker, Justin T Jordan, et al.
Cancer|September 11, 2019
Successful anti-CD19 CAR T-cell therapy in HIV-infected patients with refractory high-grade B-cell lymphomaJeremy S Abramson, Kelly E Irwin, Matthew J Frigault, et al.
Oncotarget|July 30, 2015
A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomasRoberta L Beauchamp, Marianne F James, Patrick A DeSouza, et al.
Journal of Neuro-Oncology|March 1, 2021
Clinical, radiological and genomic features and targeted therapy in BRAF V600E mutant adult glioblastomaMary Jane Lim-Fat, Kun Wei Song, J Bryan Iorgulescu, et al.
Neuro-Oncology|February 22, 2023
Proteasomal pathway inhibition as a potential therapy for NF2-associated meningioma and schwannomaSrirupa Bhattacharyya, Janet L Oblinger, Roberta L Beauchamp, et al.
Neuro-Oncology Advances|May 22, 2023
Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2Justin T Jordan, Christina C Orr, Raquel D Thalheimer, et al.
Neurology|April 26, 2020
Attracting neurology's next generation: A qualitative study of specialty choice and perceptionsJustin T Jordan, Carolyn Cahill, Tasha Ostendorf, et al.
Neuro-Oncology Practice|April 4, 2022
Practical guidance for telemedicine use in neuro-oncologyRoy E Strowd, Erin M Dunbar, Hui K Gan, et al.
Medicine|February 1, 2018
Pain correlates with germline mutation in schwannomatosisJustin T Jordan, Miriam J Smith, James A Walker, et al.
Pageof 10

Showing results (51-60 of 92) with videos related to

Sort By:
Pageof 10
The Laryngoscope|June 13, 2025
Increased Hemorrhage During Excision of Bevacizumab-Treated NF2-Related Vestibular SchwannomasChristopher G Wood, Liana Kozanno, Anat Stemmer-Rachamimov, et al.
Contemporary Clinical Trials|August 29, 2022
Design of a randomized, placebo-controlled, phase 2 study evaluating the safety and efficacy of tanezumab for treatment of schwannomatosis-related painJennifer L W Da, Vanessa L Merker, Justin T Jordan, et al.
Cancer|September 11, 2019
Successful anti-CD19 CAR T-cell therapy in HIV-infected patients with refractory high-grade B-cell lymphomaJeremy S Abramson, Kelly E Irwin, Matthew J Frigault, et al.
Oncotarget|July 30, 2015
A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomasRoberta L Beauchamp, Marianne F James, Patrick A DeSouza, et al.
Journal of Neuro-Oncology|March 1, 2021
Clinical, radiological and genomic features and targeted therapy in BRAF V600E mutant adult glioblastomaMary Jane Lim-Fat, Kun Wei Song, J Bryan Iorgulescu, et al.
Neuro-Oncology|February 22, 2023
Proteasomal pathway inhibition as a potential therapy for NF2-associated meningioma and schwannomaSrirupa Bhattacharyya, Janet L Oblinger, Roberta L Beauchamp, et al.
Neuro-Oncology Advances|May 22, 2023
Prospective phase II trial of the dual mTORC1/2 inhibitor vistusertib for progressive or symptomatic meningiomas in persons with neurofibromatosis 2Justin T Jordan, Christina C Orr, Raquel D Thalheimer, et al.
Neurology|April 26, 2020
Attracting neurology's next generation: A qualitative study of specialty choice and perceptionsJustin T Jordan, Carolyn Cahill, Tasha Ostendorf, et al.
Neuro-Oncology Practice|April 4, 2022
Practical guidance for telemedicine use in neuro-oncologyRoy E Strowd, Erin M Dunbar, Hui K Gan, et al.
Medicine|February 1, 2018
Pain correlates with germline mutation in schwannomatosisJustin T Jordan, Miriam J Smith, James A Walker, et al.
Pageof 10